According to Merck's latest financial reports the company's current EPS (TTM) is $2.52. In 2022 the company made an earnings per share (EPS) of $7.94 an increase over its 2021 EPS that were of $7.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.55 | -67.92% |
2022 | $7.94 | 10.92% |
2021 | $7.15 | 84.68% |
2020 | $3.87 | -27.2% |
2019 | $5.32 | 63.44% |
2018 | $3.26 | 151.11% |
2017 | $1.30 | -54.58% |
2016 | $2.85 | 30.21% |
2015 | $2.19 | -61.99% |
2014 | $5.77 | 180.51% |
2013 | $2.06 | -31.82% |
2012 | $3.02 | 6.62% |
2011 | $2.83 | 626.78% |
2010 | $0.39 | -95.05% |
2009 | $7.86 | 56.36% |
2008 | $5.03 | -449.04% |
2007 | -$1.44 | -150.98% |
2006 | $2.83 | -3.32% |
2005 | $2.92 | -20.08% |
2004 | $3.66 | -10.81% |
2003 | $4.10 | -6.92% |
2002 | $4.40 | 0% |
2001 | $4.40 | 7.43% |
2000 | $4.10 | 17.93% |
1999 | $3.48 | 13.06% |
1998 | $3.07 | 15.63% |
1997 | $2.66 | 20% |
1996 | $2.22 |